This website uses first-party and third-party cookies to enhance our services and show you information related to your preferences by analysing your browsing habits. By continuing to browse our website you accept our use of cookies. You can change the settings or get more information by visiting our Cookies Policy.

Research & Development

Novintethical Pharma S.A. is Swiss company dedicated to the research and development of medical devices.

Novintethical Pharma S.A. is Noventure’s partner in research and development.

The aim of the collaboration is to develop innovative products to extend our current pipeline.

Xiledia® Under development (Gastrointestinal)

Xilaplus A Under development (Gastrointestinal)

NTC 14004 Under development (Dermatology)

NTC 14002 Under development (Oral candidiasis)

Xilaplus Duo ®Under development (Gastrointestinal)

Lactosectan ®Under development (Gastrointestinal)

Ginuril® Under development (Ginecology)

NTC14003 Under development (Allergology)


       
This area contains information intended exclusively for health professionals authorized to prescribe or dispense pharmaceutical products.
   
Calle Consejo de Ciento, 333
08007 Barcelona, Spain

Contact us

info@noventure.com
NOVENTURE S.L.
Tel: +34.93.205.27.18